Australia markets closed

Progyny, Inc. (PGNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.62-2.06 (-5.94%)
At close: 04:00PM EDT
32.86 +0.24 (+0.74%)
Pre-market: 07:58AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.23B
Enterprise value 3.14B
Trailing P/E 62.82
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.41
Price/book (mrq)11.57
Enterprise value/revenue 5.69
Enterprise value/EBITDA 144.40

Trading information

Stock price history

Beta (5Y monthly) 2.00
52-week change 3-46.52%
S&P500 52-week change 3-6.07%
52-week high 368.32
52-week low 332.06
50-day moving average 342.36
200-day moving average 348.68

Share statistics

Avg vol (3-month) 3643.49k
Avg vol (10-day) 3698.2k
Shares outstanding 591.94M
Implied shares outstanding 6N/A
Float 874.1M
% held by insiders 14.46%
% held by institutions 197.83%
Shares short (28 Apr 2022) 45.59M
Short ratio (28 Apr 2022) 410.03
Short % of float (28 Apr 2022) 47.55%
Short % of shares outstanding (28 Apr 2022) 46.10%
Shares short (prior month 30 Mar 2022) 45.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 10.09%
Operating margin (ttm)3.72%

Management effectiveness

Return on assets (ttm)3.60%
Return on equity (ttm)23.94%

Income statement

Revenue (ttm)550.71M
Revenue per share (ttm)6.11
Quarterly revenue growth (yoy)41.00%
Gross profit (ttm)112.14M
Net income avi to common (ttm)55.57M
Diluted EPS (ttm)0.56
Quarterly earnings growth (yoy)-67.20%

Balance sheet

Total cash (mrq)105.68M
Total cash per share (mrq)1.15
Total debt (mrq)8.42M
Total debt/equity (mrq)3.01
Current ratio (mrq)2.40
Book value per share (mrq)3.05

Cash flow statement

Operating cash flow (ttm)14.24M
Levered free cash flow (ttm)9.91M